tiprankstipranks
2 Best Stocks to Buy Now, 12/8/2023, According to Top Analysts 
Stock Analysis & Ideas

2 Best Stocks to Buy Now, 12/8/2023, According to Top Analysts 

Which stocks are best to buy now? According to Top Wall Street Analysts, the two stocks listed below are Strong Buys. Each stock received a new Buy rating recently and has a significant upside as well. 

Pick the best stocks and maximize your portfolio:

To find more stocks like these, take a look at TipRanks’ Analyst Top Stocks tool. It shows you a real-time list of all stocks that have been recently rated by Top-ranking Analysts. 

Here are today’s top stock picks, according to analysts. Click on any ticker to thoroughly research the stock before you decide whether to add it to your portfolio. 

Praxis Precision Medicines (NASDAQ:PRAX) –  This is a clinical-stage biopharmaceutical company.  Yesterday, Piper Sandler analyst Yasmeen Rahimi assigned a Buy rating on the stock with a price target of $270. In the last three months, all four Top Analysts covering the stock have rated it a Buy. Collectively, their 12-month price targets imply an upside of nearly 219%.

Pure Storage (NYSE:PSTG– This company develops all-flash data storage hardware and software products. Yesterday, Guggenheim analyst Howard Ma initiated coverage on the stock with a Buy rating and a price target of $48. Interestingly, nine out of the 11 Top Analysts who recently rated the stock gave it a Buy. Collectively, their 12-month price targets imply an upside of nearly 32%.

Who are the Top Analysts? 

TipRanks ranks financial analysts according to the success rates of their ratings and the average return on each of their ratings. The Top Analysts have each earned a five-star ranking, thanks to the accuracy and profitability of their ratings over time.  See real-time analyst rankings and learn more about the performance of Top Analysts on TipRanks’ Top Wall Street Analysts page. 

Disclosure 

Related Articles
TheFlyPraxis Precision management to meet with Oppenheimer
TheFlyGeneDx expands access to exome testing for pediatric epilepsy patients
TheFlyPraxis Precision to present preclinical, clinical data from epilepsy programs
Go Ad-Free with Our App